Sexual dimorphism and thyroid dysfunction: A matter of oxidative stress?

Journal of Endocrinology

Volumn 221, Issue 2, 2014, Pages

  Fortunato, Rodrigo S ^a   Ferreira, Andrea C F ^a   Hecht, Fabio ^a   Dupuy, Corinne ^b   Carvalho, Denise P ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Estrogen; NADPH oxidases; Reactive oxygen species; Thyroid

Indexed keywords

CATALASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR; GLUTATHIONE PEROXIDASE 3; HISTONE H2AX; HYDROGEN PEROXIDE; PEROXIREDOXIN; PHOSPHOLIPASE C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE DISMUTASE; THYROID PEROXIDASE; ESTROGEN RECEPTOR;

ADULT; APICAL MEMBRANE; APOPTOSIS; CALCIUM TRANSPORT; CELL GROWTH; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CELL SURFACE; CONGENITAL HYPOTHYROIDISM; DNA DAMAGE; DNA REPLICATION; ENDOPLASMIC RETICULUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; ESTROGEN RESPONSIVE ELEMENT; ESTRUS CYCLE; GENE EXPRESSION; GENOMIC INSTABILITY; GONADECTOMY; GRAVES DISEASE; HASHIMOTO DISEASE; HISTONE PHOSPHORYLATION; HORMONE RECEPTOR INTERACTION; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS THYROID SYSTEM; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LIVER CELL; NEUTROPHIL; NONHUMAN; ONCOGENE RAS; OVARIECTOMY; OVARY FOLLICLE CELL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POORLY DIFFERENTIATED THYROID CANCER; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RESPIRATORY BURST; REVIEW; SECOND MESSENGER; SENESCENCE; SEX DIFFERENCE; SOMATIC MUTATION; THYROID CANCER; THYROID CANCER CELL LINE; THYROID CARCINOMA; THYROID CELL; THYROID DISEASE; THYROID FOLLICLE CELL; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE SYNTHESIS; ANIMAL; DRUG EFFECTS; FEMALE; MALE; METABOLISM; PHYSIOLOGY; RAT; SEXUAL DEVELOPMENT; THYROID DISEASES;

ANIMALS; ESTROGENS; FEMALE; HUMANS; MALE; OXIDATIVE STRESS; RATS; RECEPTORS, ESTROGEN; SEX CHARACTERISTICS; THYROID DISEASES; THYROID GLAND;

EID: 84899840487     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0588     Document Type: Review

References (103)

1. Abdel-Dayem MM&Elgendy MS 2009 Effects of chronic estradiol treatment on the thyroid gland structure and function of ovariectomized rats. BMC Research Notes 2 173. (doi:10.1186/1756-0500-2-173)
2. 2-generating activity. Journal of Biological Chemistry 280 30046-30054. (doi:10.1074/jbc.M500516200)
3. Ameziane-El-Hassani R, Boufraqech M, Lagente-Chevallier O, Weyemi U, Talbot M, Métivier D, Courtin F, Bidart JM, El Mzibri M, Schlumberger M et al. 2010 Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells. Cancer Research 70 4123-4132. (doi:10.1158/0008-5472.CAN-09-4336)
4. Arain SA, Shah MH, Meo SA&Jamal Q 2003 Estrogen receptors in human thyroid gland. An immunohistochemical study. Saudi Medical Journal 24 174-178.
5. de Araujo LF, Grozovsky R, dos Santos Pereira MJ, de Carvalho JJ, Vaisman M&Carvalho DP 2010 Expressions of vascular endothelial growth factor and nitric oxide synthase III in the thyroid gland of ovariectomized rats are upregulated by estrogen and selective estrogen receptor modulators. Thyroid 20 85-92. (doi:10.1089/thy.2009.0246)
6. Banu SK, Govindarajulu P&AruldhasMM 2002 Testosterone and estradiol up-regulate androgen and estrogen receptors in immature and adult rat thyroid glands in vivo. Steroids 67 1007-1014. (doi:10.1016/S0039-128X(02)00063-6)
7. Berdad K&Krause KH 2007 The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 87 245-313. (doi:10.1152/physrev.00044.2005)
8. Block K&Gorin Y 2012 Aiding and abetting roles of NOX oxidases in cellular transformation. Nature Reviews. Cancer 12 627-637. (doi:10.1038/nrc3339)
9. Boccabella AV&Alger EA 1964 Influence of estradiol on thyroid: serum radioiodine concentration ratios of gonadectomized and hypophysectomized rats. Endocrinology 74 680-688. (doi:10.1210/endo-74-5-680)
10. BöttnerM & WuttkeW 2005 Chronic treatment with low doses of estradiol affects pituitary and thyroid function in young and middle-aged ovariectomized rats. Biogerontology 6 261-269. (doi:10.1007/s10522-005-2623-2)
11. Braverman LE&Utiger RD 2000 Introduction to hypothyroidism. In The Thyroid: a Fundamental and Clinical Text, 8th edn, pp 61-84. Eds LE Braverman&RD Utiger. New York: Lippincott-Raven.
12. Brent GA&Davies TF 2011 Hypothyroidism and thyroiditis. In Williams Textbook of Endocrinology, 12th edn, pp 406-439. Eds S Melmed, KS Polonsky, PR Larsen&HM Kronemberg. Philadelphia: W.B. Saunders Company.
13. Bresson D, Rebuffat SA, Nguyen B, Banga JP, Gardas A&Peraldi-Roux S 2005 New insights into the conformational dominant epitopes on thyroid peroxidase recognized by human autoantibodies. Endocrinology 146 2834-2844. (doi:10.1210/en.2005-0038)
14. Burek CL&Rose NR 2008 Autoimmune thyroiditis and ROS. Autoimmunity Reviews 7 530-537. (doi:10.1016/j.autrev.2008.04.006)
15. Catusse J, Wollner S, Leick M, Schröttner P, Schraufstätter I&Burger M 2010 Attenuation of CXCR4 responses by CCL18 in acute lymphocytic leukemia B cells. Journal of Cellular Physiology 225 792-800. (doi:10.1002/jcp.22284)
16. Ceresini G, Morganti S, Graiani V, Saccani M, Milli B, Usberti E, Valenti G, Ceda GP&Corcione L 2006 Estrogen receptor (ER)-b, but not ER-a, is present in thyroid vessels: immunohistochemical evaluations in multinodular goiter and papillary thyroid carcinoma. Thyroid 16 1215-1220. (doi:10.1089/thy.2006.16.1215)
17. Chen HJ&Walfish PG 1978 Effects of estradiol benzoate on thyroid-pituitary function in female rats. Endocrinology 103 1023-1030. (doi:10.1210/endo-103-4-1023)
18. Chen K, Kirber MT, Xiao H, Yang Y&Keaney JF Jr 2008a Regulation of ROS signal transduction by NADPH oxidase 4 localization. Journal of Cell Biology 181 1129-1139. (doi:10.1083/jcb.200709049)
19. Chen GG, Vlantis AC, Zeng Q&van Hasselt CA 2008b Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Current Cancer Drug Targets 8 367-377. (doi:10.2174/156800908785133150)
20. Couse JF&Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocrine Reviews 20 358-417. (doi:10.1210/edrv.20.3.0370)
21. Cui J, Shen Y&Li R 2013 Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends in MolecularMedicine 19 197-209. (doi:10.1016/j.molmed.2012.12.007)
22. Dai G, Levy O&Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379 485-460. (doi:10.1038/379458a0)
23. De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE&Miot F 2000 Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. Journal of Biological Chemistry 275 23227-23233. (doi:10.1074/jbc.M000916200)
24. Doe RP, Mellinger GT, SwaimWR&Seal US 1967 Estrogen dosage effects on serum proteins: a longitudinal study. Journal of Clinical Endocrinology and Metabolism 27 1081-1086. (doi:10.1210/jcem-27-8-1081)
25. Dohan O, Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS & Carrasco N 2003 The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine Reviews 24 48-77. (doi:10.1210/er.2001-0029)
26. Donkó A, Ruisanchez E, Orient A, Enyedi B, Kapui R, Péterfi Z, de Deken X, Benyó Z&Geizt M 2010 Urothelial cells produce hydrogen peroxide through the activation of Duox1. Free Radical Biology&Medicine 49 2040-2048. (doi:10.1016/j.freeradbiomed.2010.09.027)
27. Dowling JT, Freinkel N&Ingbar SH 1956 Effect of diethylstilbestrol on the binding of thyroxine in serum. Journal of Clinical Endocrinology and Metabolism 16 1491-1506. (doi:10.1210/jcem-16-11-1491)
28. Driessens N, Versteyhe S, Ghaddhab C, Burniat A, De Deken X, Van Sande J, Dumont JE, Miot F&Corvilain B 2009 Hydrogen peroxide induces DNA single- and double-strand breaks in thyroid cells and is therefore a potential mutagen for this organ. Endocrine-Related Cancer 16 845-856. (doi:10.1677/ERC-09-0020)
29. Dupuy C, Ohayon R, Valent A, Noel-Hudson MS, Deme D&Virion A 1999 Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cDNAs. Journal of Biological Chemistry 274 37265-37269. (doi:10.1074/jbc.274.52.37265)
30. Duthoit C, Estienne V, Delom F, Durand-Gorde JM, Mallet B, Carayon P & Ruf J 2000 Production of immunoreactive thyroglobulin C-terminal fragments during thyroid hormone synthesis. Endocrinology 141 2518-2525. (doi:10.1210/endo.141.7.7573)
31. Egawa C, Miyoshi Y, Iwao K, Shiba E&Noguchi S 2001 Quantitative analysis of estrogen receptor-α and -β messenger RNA expression in normal and malignant thyroid tissues by real-time polymerase chain reaction. Oncology 61 293-298. (doi:10.1159/000055336)
32. Eskandari S, Loo DDF, Dai G, Levy O, Wright EM&Carrasco N 1997 Thyroid NaC/IK symporter - mechanism, stoichiometry, and specificity. Journal of Biological Chemistry 272 27230-27238. (doi:10.1074/jbc.272.43.27230)
33. Fortunato RS, Lima de Souza EC, Ameziane-el Hassani R, Boufraqech M, Weyemi U, Talbot M, Lagente-Chevallier O, de Carvalho DP, Bidart JM, Schlumberger M et al. 2010 Functional consequences of dual oxidasethyroperoxidase interaction at the plasma membrane. Journal of Clinical Endocrinology and Metabolism 95 5403-5411. (doi:10.1210/jc.2010-1085)
34. Fortunato RS, Braga WMO, Ortenzi VH, Rodrigues DC, Andrade BM, Miranda-Alves L, Rondinelli E, Dupuy C, Ferreira ACF&Carvalho DP 2013 Sexual dimorphism of thyroid reactive oxygen species production due to higher NADPH oxidase 4 expression in female thyroid glands. Thyroid 23 111-119. (doi:10.1089/thy.2012.0142)
35. Furlanetto TW, Nguyen LQ&Jameson JL 1999 Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5. Endocrinology 140 5705-5711. (doi:10.1210/endo.140.12.7197)
36. Furlanetto TW, Nunes RB Jr, Sopelsa AM&Maciel RM 2001 Estradiol decreases iodide uptake by rat thyroid follicular FRTL-5 cells. Brazilian Journal of Medical and Biological Research 34 259-263. (doi:10.1590/S0100-879X2001000200015)
37. Gantus MA, Alves LM, Stipursky J, Souza EC, Teodoro AJ, Alves TR, Carvalho DP, Martinez AM, Gomes FC&Nasciutti LE 2011 Estradiol modulates TGF-b1 expression and its signaling pathway in thyroid stromal cells. Molecular and Cellular Endocrinology 337 71-79. (doi:10.1016/j.mce.2011.02.001)
38. Gérard AC, Poncin S, Audinot JN, Denef JF&Colin IM 2009 Iodide deficiency-induced angiogenic stimulus in the thyroid occurs via HIF- and ROS-dependent VEGF-A secretion from thyrocytes. American Journal of Physiology. Endocrinology and Metabolism 296 E1414-E1422. (doi:10.1152/ajpendo.90876.2008)
39. Ginabreda MG, Cardoso LC, Nobrega FM, Ferreira AC, Gonçalves MD, Vaisman M&Carvalho DP 2008 Negative correlation between thyroperoxidase and dual oxidase H2O2-generating activities in thyroid nodular lesions. European Journal of Endocrinology 158 223-227. (doi:10.1530/EJE-07-0602)
40. Glinoer D, McGuire RA, Gershengorn MC, Robbins J&Berman M 1977 Effects of estrogen on thyroxine-binding globulin metabolism in rhesus monkeys. Endocrinology 100 9-17. (doi:10.1210/endo-100-1-9)
41. Grasberger H 2010 Defects of thyroidal hydrogen peroxide generation in congenital hypothyroidism. Molecular and Cellular Endocrinology 322 99-106. (doi:10.1016/j.mce.2010.01.029)
42. Grasberger H&Refetoff S 2006 Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. Journal of Biological Chemistry 281 18269-18272. (doi:10.1074/jbc.C600095200)
43. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P&Chambon P 1986 Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320 134-139. (doi:10.1038/320134a0)
44. Haas MJ, Raheja P, Jaimungal S, Sheikh-Ali M&Mooradian AD 2012 Estrogen-dependent inhibition of dextrose-induced endoplasmic reticulum stress and superoxide generation in endothelial cells. Free Radical Biology & Medicine 52 2161-2167. (doi:10.1016/j.freeradbiomed.2012.04.009)
45. Hampl R, Němec J, Heresová J, Kimlová I&Stárka L 1985 Estrogen receptors in human goitrous and neoplastic thyroid. Endocrinologia Experimentalis 19 227-230.
46. Hiasa Y, Nishioka H, Kitahori Y, Yane K, Nakaoka S, Ohshima M, Konishi N, Nishii K, Kitamura M&Matsunaga T 1993 Immunohistochemical analysis of estrogen receptors in 313 paraffin section cases of human thyroid tissue. Oncology 50 132-136. (doi:10.1159/000227164)
47. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA&Braverman LE 2002 Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism 87 489-499. (doi:10.1210/jcem.87.2.8182)
48. Jaklic BR, Rushin J&Ghosh BC 1995 Estrogen and progesterone receptors in thyroid lesions. Annals of Surgical Oncology 2 429-434. (doi:10.1007/BF02306376)
49. Johnson KR, Marden CC, Ward-Bailey P, Gagnon LH, Bronson RT & Donahue LR 2007 Congenital hypothyroidism, dwarfism, and heariong impairment caused by a missence mutation in the mouse dual oxidase 2 gene, Duox2. Molecular Endocrinology 21 1593-1602. (doi:10.1210/me. 2007-0085)
50. Kumar P, Wu Q, Chambliss KL, Yuhanna IS, Mumby SM, Mineo C, Tall GG & Shaul PW 2007 Direct interactions with G a i and G bg mediate nongenomic signaling by estrogen receptor α. Molecular Endocrinology 21 1370-1380. (doi:10.1210/me.2006-0360)
51. Kumar A, Klinge CM&Goldstein RE 2010 Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors α and β. International Journal of Oncology 36 1067-1080. (doi:10.3892/ijo_00000629)
52. Lacroix L, Nocera M, Mian C, Caillou B, Virion A, Dupuy C, Filetti S, Bidart JM&Schlumberger M 2001 Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Thyroid 11 1017-1023. (doi:10.1089/105072501753271699)
53. Leto TL, Morand S, Hurt D&Ueyama T 2009 Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxidants&Redox Signaling 11 2607-2619. (doi:10.1089/ars.2009.2637)
54. Levin ER 2009 Plasma membrane estrogen receptors. Trends in Endocrinology and Metabolism 20 477-482. (doi:10.1016/j.tem.2009.06.009)
55. Lima LP, Barros IA, Lisbôa PC, Araújo RL, Silva AC, Rosenthal D, Ferreira AC & Carvalho DP 2006 Estrogen effects on thyroid iodide uptake and thyroperoxidase activity in normal and ovariectomized rats. Steroids 71 653-659. (doi:10.1016/j.steroids.2006.03.007)
56. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassègue B&Griendling KK 2009 Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circulation Research 105 249-259. (doi:10.1161/CIRCRESAHA.109.193722)
57. Maier J, van Steeg H, van Oostrom C, Karger S, Paschke R&Krohn K 2006 Deoxyribonucleic acid damage and spontaneous mutagenesis in the thyroid gland of rats and mice. Endocrinology 147 3391-3397. (doi:10.1210/en.2005-1669)
58. Mandel SJ, Larsen PR&Davies TF 2011 Thyrotoxicosis. In Williams Textbook of Endocrinology, 12th edn, pp 362-405. Eds S Melmed, KS Polonsky, PR Larsen&HM Kronemberg. Philadelphia: W.B. Saunders Company.
59. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P et al. 1995 The nuclear receptor superfamily: the second decade. Cell 83 835-839. (doi:10.1016/0092-8674(95)90199-X)
60. Manole D, Schildknecht B, Gosnell B, Adams E&DerwahlM 2001 Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. Journal of Clinical Endocrinology and Metabolism 86 1072-1077. (doi:10.1210/jcem.86.3.7283)
61. Marassi MP, Fortunato RS, da Silva AC, Pereira VS, Carvalho DP, Rosenthal D&da Costa VM 2007 Sexual dimorphism in thyroid function and type 1 iodothyronine deiodinase activity in pre-pubertal and adult rats. Journal of Endocrinology 192 121-130. (doi:10.1677/joe.1.06901)
62. Marino M, Galluzzo P&Ascenzi P 2006 Estrogen signaling multiple pathways to impact gene transcription. Current Genomics 7 497-508. (doi:10.2174/138920206779315737)
63. McIntosh RE&Weetman AP 1997 Molecular analysis of the antibody response, to thyroglobulin and thyroid peroxidase. Thyroid 7 471-487. (doi:10.1089/thy.1997.7.471)
64. Métayé T, Millet C, Kraimps JL, Aubouin B, Barbier J&Bégon F 1993 Estrogen receptors and cathepsin D in human thyroid tissue. Cancer 72 1991-1996. (doi:10.1002/1097-0142(19930915)72:6%3C;1991::AIDCNCR2820720633%3E;3.0.CO;2-M)
65. Molteni A, Bahu RM, Battifora HA, Fors EM, Reddy JK, Rao MS & Scarpelli DG 1979 Estradiol receptor assays in normal and neoplastic tissues. A possible diagnostic acid for tumor differentiation. Annals of Clinical Laboratory Science 9 103-108.
66. Morand S, Ueyama T, Tsujibe S, Saito N, Korzeniowska A&Leto TL 2009 Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation. FASEB Journal 23 1205-1218. (doi:10.1096/fj.08-120006)
67. Pantaleão TU, Mousovich F, Rosenthal D, Padrón AS, Carvalho DP & Corrêa da Costa VM 2010 Effect of serum estradiol and leptin levels on thyroid function, food intake and body weight gain in female Wistar rats. Steroids 75 638-642. (doi:10.1016/j.steroids.2010.03.009)
68. Pedram A, Razandi M&Levin ER 2006 Nature of functional estrogen receptors at the plasma membrane. Molecular Endocrinology 20 1996-2009. (doi:10.1210/me.2005-0525)
69. Poncin S, Gérard AC, Boucquey M, Senou M, Calderon PB, Knoops B, Lengelé B, Many MC&Colin IM 2008 Oxidative stress in the thyroid gland: from harmlessness to hazard depending on the iodine content. Endocrinology 149 424-433. (doi:10.1210/en.2007-0951)
70. Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK & Kelly MJ 2003 Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. Journal of Neuroscience 23 9529-9540.
71. Qiu J, Bosch MA, Tobias SC, Krust A, Graham SM, Murphy SJ, Korach KS, Chambon P, Scanlan TS, Rønnekleiv OK et al. 2006 A G protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis. Journal of Neuroscience 26 5649-5655. (doi:10.1523/JNEUROSCI.0327-06.2006)
72. Raad H, Eskalli Z, Corvilain B, Miot F&De Deken X 2013 Thyroid hydrogen peroxide production is enhanced by the Th2 cytokines, IL-4 and IL-13, through increased expression of the dual oxidase 2 and its maturation factor DUOXA2. Free Radical Biology&Medicine 56 216-225. (doi:10.1016/j.freeradbiomed.2012.09.003)
73. Razandi M, Pedram A, Greene GL&Levin ER 1999 Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERa and ERb expressed in Chinese hamster ovary cells. Molecular Endocrinology 13 307-319. (doi:10.1210/mend.13.2.0239)
74. Richardson TE, Yu AE, Wen Y, Yang SH&Simpkins JW 2012 Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts. PLoS ONE 7 e34600. (doi:10.1371/journal.pone.0034600)
75. Robbins J&Nelson JH 1958 Thyroxine binding by serum protein in pregnancy and in the newborn. Journal of Clinical Investigation 37 153-159. (doi:10.1172/JCI103593)
76. Roepke TA, Bosch MA, Rick EA, Lee B, Wagner EJ, Seidlova-Wuttke D, WuttkeW, Scanlan TS, Rønnekleiv OK&Kelly MJ 2010 Contribution of a membrane estrogen receptor to the estrogenic regulation of body temperature and energy homeostasis. Endocrinology 151 4926-4937. (doi:10.1210/en.2010-0573)
77. Ruf J&Carayon P 2006 Structural and functional aspects of thyroid peroxidase. Archives of Biochemistry and Biophysics 445 269-277. (doi:10.1016/j.abb.2005.06.023)
78. Salmeen A, Park BO&Meyer T 2010 The NADPH oxidases NOX4 and DUOX2 regulate cell cycle entry via a p53-dependent pathway. Oncogene 29 4473-4484. (doi:10.1038/onc.2010.200)
79. Salvatore D, Davies TF, Schlumberger MJ, Hay ID&Larsen PR 2011 Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In Williams Textbook of Endocrinology, 12th edn, pp 362-405. Eds S Melmed, KS Polonsky, PR Larsen&HM Kronemberg. Philadelphia: W.B. Saunders Company.
80. Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J&YueW 2009 Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Annals of the New York Academy of Sciences 1155 132-140. (doi:10.1111/j.1749-6632.2008.03685.x)
81. Scandalios JG 2005 Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Brazilian Journal of Medical and Biological Research 38 995-1014. (doi:10.1590/S0100-879X2005000700003)
82. Schaefer CJ, Geelhoed GW&Dadu P 1986 Thyroid disorders and steroid receptor proteins. American Surgeon 52 514-518.
83. Schweizer U, Chiu J&Köhrle J 2008 Peroxides and peroxide-degrading enzymes in the thyroid. Antioxidants&Redox Signaling 10 1577-1592. (doi:10.1089/ars.2008.2054)
84. Seidlová-Wuttke D, Jarry H, Christoffel J, Rimoldi G&Wuttke W 2005 Effects of bisphenol-A (BPA), dibutylphtalate (DBP), benzophenone-2 (BP2), procymidone (Proc), and linurone (Lin) on fat tissue, a variety of hormones and metabolic parameters: a 3 months comparison with effects of estradiol (E2) in ovariectomized (ovx) rats. Toxicology 213 13-24. (doi:10.1016/j.tox.2005.05.001)
85. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL&Jhiang SM 1996 Cloning of the human sodium iodide symporter. Biochemical and Biophysical Research Communications 226 339-345. (doi:10.1006/bbrc.1996.1358)
86. Song Y, Ruf J, Lothaire P, Dequanter D, Andry G, Willemse E, Dumont JE, Van Sande J&De Deken X 2010 Association of duoxes with thyroid peroxidase and its regulation in thyrocytes. Journal of Clinical Endocrinology and Metabolism 95 375-382. (doi:10.1210/jc.2009-1727)
87. Sosić-Jurjević B, Filipović B, Milosević V, Nestorović N, Manojlović-Stojanoski M, Brkić B&Sekulić M 2005 Chronic estradiol exposure modulates thyroid structure and decreases T4 and T3 serum levels in middle-aged female rats. Hormone Research 63 48-54. (doi:10.1159/000083139)
88. Spencer NY, Yan Z, Boudreau RL, Zhang Y, Luo M, Li Q, Tian X, Shah AM, Davisson R, Davidson B et al. 2011 Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4. Journal of Biological Chemistry 286 8977-8987. (doi:10.1074/jbc.M110.193821)
89. Stanley JA, Aruldhas MM, Yuvaraju PB, Banu SK, Anbalagan J, Neelamohan R, Annapoorna K&Jayaraman G 2010 Is gender difference in postnatal thyroid growth associated with specific expression patterns of androgen and estrogen receptors? Steroids 75 1058-1066. (doi:10.1016/j.steroids.2010.06.009)
90. Tavangar SM, Monajemzadeh M, Larijani B&Haghpanah V 2007 Immunohistochemical study of oestrogen receptors in 351 human thyroid glands. Singapore Medical Journal 48 744-747.
91. Thomasz L, Oglio R, Randi AS, Fernandez M, Dagrosa MA, Cabrini RL, Juvenal GJ&Pisarev MA 2010 Biochemical changes during goiter induction by methylmercaptoimidazol and inhibition by deltaiodolactone in rat. Thyroid 20 1003-1013. (doi:10.1089/thy.2009.0257)
92. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly ES Jr, Nethrapalli IS&Tinnikov AA 2002 ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. Journal of Neuroscience 22 8391-8401.
93. TunbridgeWM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T&Smith PA 1977 The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology 7 481-493. (doi:10.1111/j.1365-2265.1977.tb01340.x)
94. Vaiman M, Olevson Y, Habler L, Kessler A, Zehavi S&Sandbank J 2010 Diagnostic value of estrogen receptors in thyroid lesions. Medical Science Monitor 16 BR203-BR207.
95. Vander JB, Gaston EA&Dawber TR 1968 The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Annals of Internal Medicine 69 537-540. (doi:10.7326/0003-4819-69-3-537)
96. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F et al. 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology 43 55-68. (doi:10.1111/j.1365-2265.1995.tb01894.x)
97. Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Andò S&Maggiolini M 2006 17β-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30. Molecular Pharmacology 70 1414-1423. (doi:10.1124/mol.106.026344)
98. Weyemi U&Dupuy C 2012 The emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses. Mutation Research 751 77-81. (doi:10.1016/j.mrrev.2012.04.002)
99. Weyemi U, Caillou B, Talbot M, Ameziane-El-Hassani R, Lacroix L, Lagent-Chevallier O, Al Ghuzlan A, Roos D, Bidart JM, Virion A et al. 2010 Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues. Endocrine-Related Cancer 17 27-37. (doi:10.1677/ERC-09-0175)
100. Weyemi U, Lagente-Chevallier O, Boufraqech M, Prenois F, Courtin F, Caillou B, Talbot M, Dardalhon M, Al Ghuzlan A, Bidart JM et al. 2012 ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene 31 1117-1129. (doi:10.1038/onc.2011.327)
101. Yane K, Kitahori Y, Konishi N, Okaichi K, Ohnishi T, Miyahara H, Matsunaga T, Lin JC&Hiasa Y 1994 Expression of the estrogen receptor in human thyroid neoplasms. Cancer Letters 84 59-66. (doi:10.1016/0304-3835(94)90358-1)
102. Yue W, Wang JP, Li Y, Fan P, Liu G, Zhang N, Conaway M, Wang H, Korach KS, Bocchinfuso W et al. 2010 Effects of estrogen on breast cancer development: role of estrogen receptor independent mechanisms. International Journal of Cancer 127 1748-1757. (doi:10.1002/ijc.25207)
103. Zeng Q, Chen GG, Vlantis AC&van Hasselt CA 2007 Oestrogen mediates the growth of human thyroid carcinoma cells via an oestrogen receptor-ERK pathway. Cell Proliferation 40 921-935. (doi:10.1111/j.1365-2184.2007.00471.x)